Patent Revenue definition

Patent Revenue means any monies, royalties, payments, cash equivalent (including non-cash consideration), or other consideration received by BRT or any of its Affiliates from third parties from the use, lease, other commercialization, licensing, infringement, litigation (after deduction of all reasonable costs of litigation directly related to achieve recovery) or Sale of the Patents. In no event will “Patent Revenue” include any of the following: (a) cash, quantity and other trade discounts, credits or allowances; (b) credits or allowances granted upon returns, rejections or recalls; (c) amounts payable resulting from governmental (or any agency thereof) mandated rebate programs; (d) chargebacks and other amounts paid on the sale or dispensing of Products; (e) taxes, tariffs and duties; (f) transportation, freight, postage, importation, insurance and other handling expenses; (g) delayed ship order credits; (h) discounts pursuant to indigent patient programs and patient discount programs and coupon discounts; (i) amounts received from Foundation or the University or any Affiliate thereof; (j) amounts received as grants from any governmental body, quasi-governmental body or foundation; or (k) amounts received from third parties in connection with clinical trials.
Sample 1
Patent Revenue is defined below in Section 5.3.
Sample 1

Examples of Patent Revenue in a sentence

  • On any Distribution Date (as such term is defined in the CPR Agreement), the CPR Distributions made by Reorganized Ampex shall be fifty percent (50%) of such Net New Patent Revenue in excess of the sum of (w), (x), (y) and (z), less the amount Reorganized Ampex incurred as expenses under this Agreement or paid to the CPR Administrator as compensation or expense reimbursement pursuant to this Agreement.

  • Holders of the Distribution Rights shall be entitled to receive periodic statements from Reorganized Ampex setting forth the value, if any, of the Distribution Rights and the amount of the Net New Patent Revenue.

  • Campus will identify funding sources to cover mandatory cost increases related to UCGF/patent revenue.UC FUNDING STREAMS INITIATIVEAttachment 1 ‐ Patent Revenue ActivitiesFigures based on UCSD Financial Link $ (14,074,000) 63% $ (11,351,000) 53% $ (8,965,000) 67% $ (8,202,000) 61% $ (8,202,000) 61% B SYSTEMWIDE CONTRIBUTIONS6 UCGF ‐ 25% net Patent Revenue (a) (3,487,000) (2,562,750)7 OP‐TTO Assessment (65,000) (65,000) OP‐TTO Assessment ‐ ‐Est.

  • Information may be disclosed from these records regarding suspected cases of child abuse to:(a) Federal, state or Tribal agencies that need to know the information in the performance of their duties, and(b) members of community child protection teams for the purposes of investigating reports of s 30.

  • For theoretical justification, roughly speaking, since the sparse meta-initialization network obtained in the pruning phase generalizes well in light of Theorem 1 and Theorem 2, it is expected to serve as a good initialization for future retraining via gradient descent.

  • In both cases, the obligation to inform/consult the authorities and public of the neighbouring countries as your own in case of significant transboundary effects, is addressed (separately).

  • To the extent that collected Patent Revenue does result in GTX receiving such a running Revenue Share, at a minimum, Inventergy shall provide an advance to GTX to make up the difference which will later be offset against Revenue Share which is paid to GTX.

  • GTX agrees that it will defend, indemnify and hold each of the Entity and Inventergy harmless against (a) any assertion that one or more of the Patents has an unlisted inventor, or that any royalty or other share of Patent Revenue is otherwise due or owed to any third party, or (b) any assertion that GTX does not have the power to transfer the Patents to the Entity.

  • Upon the execution of a License Agreement, Sublicense Agreement or first Sale, BRT will, within thirty (30) days after the calendar year in which Patent Revenue first occurs, and within thirty (30) days of each July 1 and January 1 thereafter, deliver to Foundation a true and accurate written Revenue Report, giving the particulars of the business conducted with the Patents during the preceding six (6) calendar months as are pertinent to calculating payments hereunder.

  • It was a 2-day workshop on diagnosis and treatment decisions for tooth wear in senior citizens.- ORCA took part in the jury of the Yngve Ericsson prize, presented by the Swedish Patent Revenue Fund for Research in Preventive Odontology.

Related to Patent Revenue

  • Sublicense Revenues means [***].

  • Sublicense Revenue means [***].

  • Patent Costs means the reasonable fees and expenses paid to outside legal counsel, and filing, maintenance and other reasonable out-of-pocket expenses paid to Third Parties, incurred in connection with the Prosecution and Maintenance of Patent Rights.

  • Patent Expenses means the fees and expenses of outside counsel and payments to Third Parties incurred after the Effective Date in connection with the preparation, filing, prosecution and maintenance of the Licensed Patents, the Joint Collaboration Patents, and the Shire Patents covering Compound and Collaboration Products, including the costs of patent interference and opposition proceedings, net of any reimbursement of such expenses by Third Parties.

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • CREFC® Intellectual Property Royalty License Fee With respect to each Mortgage Loan (including any REO Mortgage Loan) and for any Distribution Date, the amount accrued during the related Interest Accrual Period at the CREFC® Intellectual Property Royalty License Fee Rate on, in the case of the initial Distribution Date, the Cut-Off Date Balance of such Mortgage Loan and, in the case of any subsequent Distribution Date, the Stated Principal Balance of such Mortgage Loan as of the close of business on the Distribution Date in the related Interest Accrual Period; provided that such amounts shall be computed for the same period and on the same interest accrual basis respecting which any related interest payment due or deemed due on the related Mortgage Loan is computed and shall be prorated for partial periods. For the avoidance of doubt, the CREFC® Intellectual Property Royalty License Fee shall be payable from the Lower-Tier REMIC.

  • Net Sales Revenue shall have the meaning as set out in Schedule "A"

  • Patent Rights means the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region, including all provisional applications, substitutions, continuations, continuations-in-part, divisions, renewals, all letters patent granted thereon, and all reissues, re-examinations and extensions thereof, and all foreign counterparts of any of the foregoing.

  • CREFC® Intellectual Property Royalty License Fee Rate With respect to each Mortgage Loan, a rate equal to 0.0005% per annum.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Joint Patents has the meaning set forth in Section 8.1.

  • Net Revenues means the difference between:

  • Licensee Patents means all Patents that (i) claim any inventions developed by or on behalf of Licensee in the Development, manufacture or Commercialization of any of the Products in the Field pursuant to this Agreement, or (ii) are Controlled by Licensee or its Affiliates during the Term and claim or cover any of the Products (including composition of matter, methods of manufacturing and methods of treatment or use).”

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Licensed Patent Rights means:

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Net Revenue means an entity’s total revenue less its operating expenses, interest paid, depreciation, and taxes. “Net Revenue” is synonymous with “Profit.”

  • Net Sales means [***].

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Sublicensing Revenue means all (i) cash, (ii) sublicensing fees and (iii) all other payments and the cash equivalent thereof, which are paid to LICENSEE by the Sublicensees of its rights hereunder, but excluding the following payments:

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.